Back
AN2 Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
ANTX
AN2 Therapeutics
Last Price:
1.35
Seasonality Move:
-36.32%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.AN2 Therapeutics Stock Forecast
-
Is AN2 Therapeutics Stock Undervalued?
The current AN2 Therapeutics [ANTX] share price is $1.34. The Score for ANTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - ANTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will AN2 Therapeutics Stock Go Up Next Year?
Data Unavailable
AN2 Therapeutics Stock Rating
Data Unavailable
AN2 Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
an2therapeutics.com
52-Week Data
52-Week High:
22.22
52-Week Low:
0.87
Prediction Charts
Market Cap:
40.04M
Price in USD:
1.34
Volume:
1.25M
Beta:
-0.23
Technical Analysis
SMA50:
1.07
SMA100:
1.46
SMA200:
2.15
52-Wk Change:
-91.65%
Stock Predictions
-
Is AN2 Therapeutics stock public?
Yes, AN2 Therapeutics is a publicly traded company. -
What is the AN2 Therapeutics stock quote today?
The AN2 Therapeutics stock price is 1.34 USD today. -
How to buy AN2 Therapeutics stock online?
You can buy AN2 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-5 | 1.09 | 1.09 | 1.10 | 1.08 |
| Nov-6 | 1.10 | 1.10 | 1.11 | 1.09 |
| Nov-7 | 1.10 | 1.10 | 1.11 | 1.10 |
| Nov-8 | 1.11 | 1.10 | 1.12 | 1.09 |
| Nov-11 | 1.11 | 1.09 | 1.12 | 1.08 |
| Nov-12 | 1.08 | 1.06 | 1.11 | 1.05 |
| Nov-13 | 1.06 | 1.00 | 1.07 | 1.00 |
| Nov-14 | 1.03 | 1.00 | 1.03 | 0.99 |
| Nov-15 | 1.00 | 1.00 | 1.04 | 0.99 |
| Nov-18 | 1.00 | 1.00 | 1.03 | 0.98 |
| Nov-19 | 1.03 | 1.06 | 1.11 | 1.00 |
| Nov-20 | 1.07 | 1.30 | 1.33 | 1.07 |
| Nov-21 | 1.30 | 1.23 | 1.46 | 1.20 |
| Nov-22 | 1.26 | 1.34 | 1.42 | 1.26 |
AN2 Therapeutics Earnings
Data Unavailable
AN2 Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
* AN2 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.